Greetings,

Family Health International (FHI) is pleased to announce the new
information and advocacy kit, Improving Access to Family Planning:
Community-based Distribution of DMPA. This kit provides information and
tools with which decision-makers can advocate for and initiate
community-based distribution (CBD) of the injectable contraceptive
depot-medroxyprogesterone acetate (DMPA or Depo-Provera). Drawing on
research and programs from Africa, Asia, and Latin America, the kit
presents seven briefs with evidence supporting the safety and efficacy
of CBD provision of DMPA. It discusses best practices for successful CBD
of DMPA provision, such as training, counseling, and ensuring supply.
The kit also includes overviews of resources and steps for initiating
CBD of DMPA provision within existing reproductive health programs, as
well as a checklist for screening clients who want to use DMPA. The
checklist is based on the World Health Organization's Medical
Eligibility Criteria for Contraceptive Use.

The kit is available electronically on FHI's website at:
http://www.fhi.org/en/RH/Pubs/servdelivery/cbd_dmpa/index.htm. Limited
hard copies are available and can be ordered by writing to
[log in to unmask] Please indicate how you plan to use the materials.


David Hock
Family Health International
[log in to unmask]


Access CANCHID archives at: https://listserv.yorku.ca/archives/canchid.html
plus CANCHID subscription management. CANCHID is a joint service of the Canadian Society for International Health < http:www.csih.org > and the Distributed Knowledge Project at York University.  Queries to: [log in to unmask]